247 results
Page 7 of 13
8-K
EX-99.1
k3wrzsko3wh v6sx
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
7pf6xh8lfs4q
8 Aug 11
Ligand Pharmaceuticals Announces Second Quarter Results
12:00am
8-K
EX-99.1
r55mdhaoqmf8d2cyp55
26 Jul 11
Ligand Partner GlaxoSmithKline Receives Positive Data from Promacta® PIII
12:00am
8-K
EX-99.1
v2cftvdi3ul42bn0t6cx
22 Jun 11
Product has Potential to Offer Important Advantages Over Current IV Melphalan
12:00am
8-K
EX-99.1
kcbrvqkh
20 Jun 11
Rob McKay, Sr. Dir. Business Development
12:00am
8-K
EX-99.1
4gbqk8pxsahn
10 May 11
Ligand Pharmaceuticals Reports First Quarter Results
12:00am
8-K
EX-99.1
72xuaqjydic
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
quhs4azrth0v2mu504
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
EX-99.1
b0uwdld833x8gdwrqr
15 Feb 11
Ligand Announces Fourth Quarter and Full Year 2010 Consolidated Financial Results
12:00am
8-K
EX-99.1
ds77deei6hp d9qn6r1
9 Feb 11
Ligand Appoints John L. LaMattina to Board of Directors
12:00am
8-K
EX-99.1
otyxlp6n
31 Jan 11
Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals
12:00am
8-K
EX-99.1
3xv1fzmmofzle35nswri
7 Oct 10
Regulation FD Disclosure
12:00am
8-K
ek8w0zt1qybospl031g
3 May 10
Entry into a Material Definitive Agreement
12:00am